These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 33887527)
1. Ribosomal proteins as distinct "passengers" of microvesicles: new semantics in myeloma and mesenchymal stem cells' communication. Dabbah M; Lishner M; Jarchowsky-Dolberg O; Tartakover-Matalon S; Brin YS; Pasmanik-Chor M; Neumann A; Drucker L Transl Res; 2021 Oct; 236():117-132. PubMed ID: 33887527 [TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells secretomes' affect multiple myeloma translation initiation. Marcus H; Attar-Schneider O; Dabbah M; Zismanov V; Tartakover-Matalon S; Lishner M; Drucker L Cell Signal; 2016 Jun; 28(6):620-30. PubMed ID: 26976208 [TBL] [Abstract][Full Text] [Related]
3. Microvesicles derived from normal and multiple myeloma bone marrow mesenchymal stem cells differentially modulate myeloma cells' phenotype and translation initiation. Dabbah M; Attar-Schneider O; Tartakover Matalon S; Shefler I; Jarchwsky Dolberg O; Lishner M; Drucker L Carcinogenesis; 2017 Jul; 38(7):708-716. PubMed ID: 28838065 [TBL] [Abstract][Full Text] [Related]
4. Multiple myeloma BM-MSCs increase the tumorigenicity of MM cells via transfer of VLA4-enriched microvesicles. Dabbah M; Jarchowsky-Dolberg O; Attar-Schneider O; Tartakover Matalon S; Pasmanik-Chor M; Drucker L; Lishner M Carcinogenesis; 2020 Mar; 41(1):100-110. PubMed ID: 31586190 [TBL] [Abstract][Full Text] [Related]
5. Niche origin of mesenchymal stem cells derived microvesicles determines opposing effects on NSCLC: Primary versus metastatic. Attar-Schneider O; Dabbah M; Drucker L; Gottfried M Cell Signal; 2020 Jan; 65():109456. PubMed ID: 31672605 [TBL] [Abstract][Full Text] [Related]
6. BM-MSCs-derived ECM modifies multiple myeloma phenotype and drug response in a source-dependent manner. Ibraheem A; Attar-Schneider O; Dabbah M; Dolberg Jarchowsky O; Tartakover Matalon S; Lishner M; Drucker L Transl Res; 2019 May; 207():83-95. PubMed ID: 30738861 [TBL] [Abstract][Full Text] [Related]
7. Multiple myeloma and bone marrow mesenchymal stem cells' crosstalk: Effect on translation initiation. Attar-Schneider O; Zismanov V; Dabbah M; Tartakover-Matalon S; Drucker L; Lishner M Mol Carcinog; 2016 Sep; 55(9):1343-54. PubMed ID: 26293751 [TBL] [Abstract][Full Text] [Related]
8. Multiple myeloma cells promote migration of bone marrow mesenchymal stem cells by altering their translation initiation. Dabbah M; Attar-Schneider O; Zismanov V; Tartakover Matalon S; Lishner M; Drucker L J Leukoc Biol; 2016 Oct; 100(4):761-770. PubMed ID: 27272311 [TBL] [Abstract][Full Text] [Related]
9. Secretome of human bone marrow mesenchymal stem cells: an emerging player in lung cancer progression and mechanisms of translation initiation. Attar-Schneider O; Zismanov V; Drucker L; Gottfried M Tumour Biol; 2016 Apr; 37(4):4755-65. PubMed ID: 26515338 [TBL] [Abstract][Full Text] [Related]
10. Serum deprivation elevates the levels of microvesicles with different size distributions and selectively enriched proteins in human myeloma cells in vitro. Sun L; Wang HX; Zhu XJ; Wu PH; Chen WQ; Zou P; Li QB; Chen ZC Acta Pharmacol Sin; 2014 Mar; 35(3):381-93. PubMed ID: 24374813 [TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of microvesicles from mesenchymal stem cells. Mohammadi MR; Riazifar M; Pone EJ; Yeri A; Van Keuren-Jensen K; Lässer C; Lotvall J; Zhao W Methods; 2020 May; 177():50-57. PubMed ID: 31669353 [TBL] [Abstract][Full Text] [Related]
12. BCR-ABL1-positive microvesicles malignantly transform human bone marrow mesenchymal stem cells in vitro. Fu FF; Zhu XJ; Wang HX; Zhang LM; Yuan GL; Chen ZC; Li QB Acta Pharmacol Sin; 2017 Nov; 38(11):1475-1485. PubMed ID: 28836580 [TBL] [Abstract][Full Text] [Related]
13. Suppression of Ovarian Cancer Cell Growth by AT-MSC Microvesicles. Szyposzynska A; Bielawska-Pohl A; Krawczenko A; Doszyn O; Paprocka M; Klimczak A Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266317 [TBL] [Abstract][Full Text] [Related]
14. BM-MSCs-derived microvesicles promote allogeneic kidney graft survival through enhancing micro-146a expression of dendritic cells. Wu XQ; Yan TZ; Wang ZW; Wu X; Cao GH; Zhang C Immunol Lett; 2017 Nov; 191():55-62. PubMed ID: 28963073 [TBL] [Abstract][Full Text] [Related]
15. The Role of Microvesicles Derived from Mesenchymal Stem Cells in Lung Diseases. Chen J; Li C; Chen L Biomed Res Int; 2015; 2015():985814. PubMed ID: 26064975 [TBL] [Abstract][Full Text] [Related]
16. Microvesicles derived from human umbilical cord mesenchymal stem cells ameliorate renal ischemia-reperfusion injury via delivery of miR-21. Du T; Zhou J; Chen WX; Zhang XL; Ji TY; Liu J; Rong L; Wang LD; Zhou RJ; Ding DG Cell Cycle; 2020 Jun; 19(11):1285-1297. PubMed ID: 32329653 [TBL] [Abstract][Full Text] [Related]
17. Microvescicles derived from mesenchymal stromal cells are not as effective as their cellular counterpart in the ability to modulate immune responses in vitro. Conforti A; Scarsella M; Starc N; Giorda E; Biagini S; Proia A; Carsetti R; Locatelli F; Bernardo ME Stem Cells Dev; 2014 Nov; 23(21):2591-9. PubMed ID: 24937591 [TBL] [Abstract][Full Text] [Related]
18. Differentially expressed microRNAs in bone marrow mesenchymal stem cell-derived microvesicles in young and older rats and their effect on tumor growth factor-β1-mediated epithelial-mesenchymal transition in HK2 cells. Wang Y; Fu B; Sun X; Li D; Huang Q; Zhao W; Chen X Stem Cell Res Ther; 2015 Sep; 6():185. PubMed ID: 26415502 [TBL] [Abstract][Full Text] [Related]
19. Tumor Cell-Derived Microvesicles Induced Not Epithelial-Mesenchymal Transition but Apoptosis in Human Proximal Tubular (HK-2) Cells: Implications for Renal Impairment in Multiple Myeloma. Zhao A; Kong F; Liu CJ; Yan G; Gao F; Guo H; Guo AY; Chen Z; Li Q Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28264449 [TBL] [Abstract][Full Text] [Related]
20. Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury. Bruno S; Grange C; Collino F; Deregibus MC; Cantaluppi V; Biancone L; Tetta C; Camussi G PLoS One; 2012; 7(3):e33115. PubMed ID: 22431999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]